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ABSTRACT
Background: Hemostatic alterations have already been well characterized in humans with body fat excess, being included 
in the list of obesity related comorbidities. Overweight and obesity are common in dogs; however, there is little information 
about the blood coagulation parameters in dogs with these conditions. The aim of this study was to compare hematological 
and coagulation parameters between lean dogs and overweight or obese dogs, including platelets count; prothrombin time 
(PT); activated partial thromboplastin time (aPTT), coagulation time (CT) and plasma fibrinogen concentration.
Materials, Methods & Results: A total of 22 dogs (aged 1 to 10 years, neutered) were evaluated, 10 of them presented 
ideal body condition score (BCS 4-5) and formed the group 1 (control) and 12 were overweight or obese (BCS 7-9) and 
formed the group 2. The dogs were submitted to clinical evaluation and then to blood collection for the following laboratory 
tests: blood count (performed on automatic analyzer), quantification of plasma proteins by refractometry, determination 
PT, aPTT and plasma fibrinogen concentration using specific commercial kits, and CT by Lee-White method. Compared 
to group 1, group 2 presented a lower leukocytes and lymphocytes counts (P < 0.05) and a higher concentration of plasma 
fibrinogen (P = 0,026), but compatible with reference values. No difference was observed in the erythrogram, platelets 
count, total plasma protein concentration, PT, aPTT and CT between the groups. BCS was negatively correlated with 
leukocytes (r = -0.45) and lymphocytes (r = -0.60) counts and positively with plasma fibrinogen concentration (r = +0.56).
Discussion: The reduction in lymphocytes led to a lower leukocytes count in the dogs of group 2. The migration of pe-
ripheral blood lymphocytes to adipose tissue has been reported in the early phase of the inflammatory process induced by 
obesity and could justify the reduction of circulating lymphocytes in overweight or obese dogs evaluated in this study; 
however, cytopathological assessment of adipose tissue was not performed. Fibrinogen has to be converted to fibrin for 
clot formation, so the concentration of this plasma protein is an important parameter for the evaluation of hemostasis. 
However, there are reports of increase in plasma fibrinogen as a result of infammatory processes. In group 2, formed by 
dogs with overweight or obese, the higher value of plasm fibrinogen concentration, associated with lower lymphocyte count, 
may suggest an early-stage inflammatory process. Similar results were described in obese humans, but also evidenced in 
obese dogs. Supporting this suggestion, the correlation analysis indicates that the higher the body fat excess (estimated 
by the BCS), the higher the fibrinogen concentration and the lower the lymphocyte count in evaluated dogs. Despite the 
higher concentration of plasma fibrinogen in group 2, no change was observed in the hemostasis of overweight or obese 
dogs, due to the normal values for platelets count, PT, aPTT and CT, excluding a hypercoagulability condition as already 
hypothesized by other authors for dogs and obese humans. The difference between our findings and the literature may be 
in the time of evolution of the disease, since we evaluated younger dogs. In conclusion, the body fat excess did not alter 
the erythrogram and the activity of the clotting factors, estimated by PT, aPTT and CT, but it interfered in the leukogram 
and increased the plasma concentration of fibrinogen in the evaluated dogs.
Keywords: body fat excess, coagulation pathways, small animals, fibrinogen.
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INTRODUCTION
According to the Global Pet Obesity Initiati-
ve Position Statement, obesity in dogs is defined as 
30% above ideal body weight [29]. There is also the 
distinction between being overweight or being obese, 
established by the body condition score (BCS) scale 
for dogs [13]. 
The excessive food intake and/or inadequate 
energy use are among the main causes of obesity in 
dogs [16]. In addition, some breeds of dogs are more 
predisposed to weight gain, such as labrador retriever, 
golden retriever and pug [3,7,25].
Obesity is increasingly present in veterinary 
medicine, mainly, because the animals share the same 
unhealthy lifestyle of their tutors, characterized by 
physical inactivity and easy access to palatable and 
calorie foods [21,22]. 
Currently, canine obesity is considered a disease 
[4], which reduces quality and life expectancy [23], due 
to several comorbidities, e.g. dyslipidemia (which incre-
ase the risk of pancreatitis) [30], diabetes mellitus, ortho-
pedic diseases, mammary and urinary tract neoplasias. 
In obese human, changes in blood coagulation were well 
characterized and include enhanced of platelet activation 
[1], increased activity of plasma coagulation factors and 
impaired fibrinolysis, with thromboembolism risk [9]. 
A single study reported the increased platelet count and 
reduction in aPTT in overweight and obese dogs [20]; 
however, little is known about the coagulation status in 
dogs with this condition.
The aim of this study was to compare hemato-
logical and coagulation parameters between lean dogs 
and overweight or obese dogs, including platelet count, 
PT, aPTT, CT and plasma fibrinogen concentration.
MATERIALS AND METHODS
Animals
Twenty-two dogs (12 females and 10 males), 
aged 1 to 10 years, neutered and of different breeds 
were evaluated. These dogs were selected in the 
Small Animal Service of the Veterinary Hospital of 
instituition. During the anamnesis, the tutors did not 
report previous diseases and the dogs presented good 
general condition. 
The dogs were divided into two groups, ac-
cording to the BCS [13]: group 1, formed by 10 dogs 
(6 males and 4 females) with BCS 4-5, considered 
ideal, and group 2, formed by 12 dogs (4 males and 8 
females) with BCS 7-9, i.e. in overweight or obesity.
The dogs were submitted to clinical and labora-
tory evaluation and only those with normal results for 
physical exam and laboratory tests or results consis-
tent with excess body fat were included in this study. 
Obese dogs with suspected or definitive diagnosis of 
metabolic diseases (such as diabetes mellitus, hypera-
drenocorticism or hypothyroidism) were not included. 
So, the justification for overweight or obesity in BCS 
7-9 group was ad libitum feeding.
Blood sample and laboratory tests 
After 8 h fasting, blood samples were perfor-
med by jugular venipuncture. Then, the blood of each 
dog was transferred to tube1: 1) with anticoagulant 
(ethylenediamine tetraacetic acid - EDTA) to per-
form the blood count, 2) containing sodium citrate 
for determination of PT, aPTT and plasma fibrinogen 
concentration, using commercial kits2 and following 
the manufacturer’s instructions, and 3) without antico-
agulant to determine CT by Lee-White method [14].
An automatic blood analyzer (BC 2800 VET)3 
was used in blood count, but the differential leukocytes 
counting was done manually, from blood smears [28]. 
Total plasma protein was measured by refractometry4. 
PT, aPTT and fibrinogen were determined by 
the clot formation method [24], from the addition of 
specific reagents in the plasma sample. The kits PT (ref. 
504)2 and aPTT (ref. 502)2 contained thromboplastin 
plus calcium chloride or ellagic acid plus phospholipids 
and calcium chloride, respectively. These reagents 
triggered the sequential activation of clotting factors, 
resulting in activated thrombin and conversion of fri-
brinogen to fibrin, evidenced by the appearance of the 
clot. PT and aPTT corresponded to time (in seconds) 
from the addition of reagents to visualization of the 
clot. In the fibrinogen kit (ref. 506)2, the reagent was 
thrombin, so, the higher the fibrinogen concentration 
in plasma sample, the faster the clot was formed. The 
time to clot formation was converted to fibrinogen 
concentration (mg/dL) using a calibration curve. CT 
corresponded to time (in minutes) since the blood 
penetrated in the syringe, until the clot was formed in 
the glass tube [14].
Statistical analysis
Data are presented as mean values ± standard 
error of the individual groups means. The results were 
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submitted to analysis of variance by F test and the mean 
values of groups 1 and 2 were compared by unpaired 
t test, using PRISM package5 (P < 0.05). Correlations 
were evaluated by the Pearson coefficient.
RESULTS
The mean values of age did not differ between 
groups (P = 0.172). The group 2 had a higher mean 
value for body weight and BCS. Breeds, individual 
and mean values of age, body weight and BCS of dogs 
from both groups are shown in Table 1.
All dogs presented normal values for the blood 
count and total plasma protein concentration [28]. Com-
paring the mean values, the total number of leukocytes 
and lymphocytes was lower in group 2 (Table 2).
No differences were found between groups for 
mean values of PT, aPTT and CT (Table 3) and the re-
sults were similar to described by other authors [5,24]. 
Fibrinogen concentration was higher in group 2 (254.4 ± 
17.00 versus 190.7 ± 20.65; P = 0.026) (Figure 1) but did 
not exceed the reference values (100 - 500 mg/dL) [28].
BCS was negatively correlated with number of 
leukocytes (r = -0.45; P = 0.037) and lymphocytes (r = 
-0.60; P = 0.003). Positive and significant correlation 
was observed between BCS and plasma fibrinogen 
concentration (r = +0.56; P = 0.007). Correlations 
between BCS and PT, aPTT and CT were weak and 
not significant.
DISCUSSION
Recent study has reported that factors such as 
age, neuter status and breed influence weight gain in 
dogs [8]. Increase in sedentary behavior [17], reduc-
tion of metabolic rate [2], composition and function 
of adipose tissue [26] and genetic predisposition [27] 
justify obesity in older dogs, neutered and some breeds.
 In the present study, group 2 was initially 
formed and all dogs in this group were neutered and 
presented overweight or obese; agreeing with epide-
miological studies that evaluated the canine obesity 
[2,6,8]. Then, to compose group 1, which would re-
present the control situation, dogs were recruited with 
ideal BCS and also neutered. The females neutered 
predisposition to obesity certainly influenced in the 
percentage of females in group 2(67%) [15].
The mean age value was numerically higher 
in group 2, but did not differ statistically from group 
1, because 67% of dogs in group 2 were aged 1 to 5 
years. In a study of international scope, the researchers 
also observed obesity in dogs from 1-year-old [6]. In 
the present study, young adult dogs presented excess 
body fat, compatible with overweight or obesity, pos-
sibly, due to early neutered associated with ad libitum
feeding. A reduced calorie diet is indicated after early 
neutered to decrease the risk of obesity in dogs [15].
Group 2 was composed of dogs of large breeds 
(33.3%), with overweight (16.7%) or obesity (83.3%); 
therefore, mean values of body weight and BCS were 
higher, compared to group 1 (P < 0.05).
Dogs of group 2 did not present alterations in 
blood count (erythrogram and leukogram) and total 
plasma protein concentration, in relation to referen-
ce values [28]; but, in comparison to group 1, the 
lymphocytes count was lower, also reducing the total 
leukocytes count. In addition, a negative correlation 
was found between BCS and count of leukocytes and 
lymphocytes. The excess body fat in the dogs evalua-
ted may have led to the reduction of circulating lym-
phocytes, interfering with the total leukocytes count. 
In humans and mice, the migrati on of peripheral blood 
lymphocytes to adipose tissue has been reported in the 
early phase of the inflammatory process induced by 
obesity [10]; however, cytopathological assessment of 
adipose tissue was not performed in this study.
In accordance with present results, the reduc-
tion of circulating lymphocytes in overweight and 
obese dogs was reported in a previous research [20]. 
However, these authors did not find differences in 
total leukocytes count but evidenced an increase in 
platelets count in the group of overweight and obese 
Figure 1. Concentration of plasma fibrinogen in dogs. Group 2, formed 
by dogs with body condition score between 7-9, had a higher average 
fibrinogen concentration than dogs of group 1, with body condition score 
between 4-5. *P = 0.026 versus group 1. N = number of dogs in each group.
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Table 1. Description of breeds, individual and mean values of age, body weight and body condition score (BCS) of selected dogs.
Group 1 (N = 10) Group 2 (N = 12)
Dog Breed Age (years) Body weight (Kg) BCS Breeds Age (years)
Body weight 
(Kg) BCS
1 Bc 1 17.4 5 Bmd 3 55.0 9
2 Mb 1 7.4 4 Eb 1 27.2 9
3 Mb 1 6.3 5 Gr 5 35.0 9
4 Mb 1 14.5 5 Pitbull 3 23.3 7
5 Mb 2 11.6 5 Pitbull 5 30.0 8
6 Mb 4 18.0 5 Pug 1 7.9 8
7 Mb 5 12.4 5 Mb 1 14.5 7
8 Mb 5 15.3 5 Mb 4 15.2 8
9 Mb 8 15.6 4 Mb 6 24.4 9
10 Shitzu 1 4.7 5 Mb 8 15.0 9
11 --- --- --- --- Mb 8 19.6 8
12 --- --- --- --- Mb 10 16.2 8
Mean ± SE --- 2.90 ± 0.78 12.32 ± 1.50 4.80 ± 0.13 -- 4.58 ± 0.87 23.60 ± 3.60* 8.25 ± 0.22*
N= number of dogs in each group. Bc= Border collie. Mb= Mixed breed. Bmd= Bernese mountain dog. Eb= English bulldog. Gr= Golden retriever. 
SE= standard error. *P < 0.05 versus group 1.
Table 2. Mean values of blood count and total plasma protein concentration of groups 1 and 2.
Parameter Group 1 (N = 10) Group 2 (N = 12) P value
Erythrocytes (/µL) 6.75 ± 0.27 6.45 ± 0.21 0.388
Hematocrit (%) 49.89 ± 1.93 46.83 ± 1.78 0.258
Hemoglobin (g/dL) 16.64 ± 0.68 15.53 ± 0.64 0.249
MCV (fL) 73.98 ± 0.46 72.50 ± 0.77 0.130
MCH (pg) 24.65 ± 0.26 24.00 ± 0.31 0.129
MCHC (%) 33.33 ± 0.24 33.09 ± 0.20 0.446
Platelets (/µL) x 103 275.60 ± 24.73 319.20 ± 23.97 0.223
Leukocytes (/µL) 9.610 ± 827.90 7.567 ± 418.90 0.031
Segmented (/µL) 5.328 ± 590.50 4.972 ± 626.80 0.576
Eosinophils (/µL) 666.50 ± 127.90 533.20 ± 92.36 0.398
Lymphocytes (/µL) 3.156 ± 394.70 1.740 ± 136.10 0.002
Monocytes (/µL) 449.30 ± 77.78 322.40 ± 60.93 0.207
Total plasma protein (g/dL) 6.72 ± 0.14 7.05 ± 0.31 0.375
N= number of dogs in each group. MCV= mean corpuscular volume; MCH= mean corpuscular hemoglobin; MCHC= medium corpuscular hemo-
globin concentration.
Table 3. Mean values of prothrombin time (PT), activated partial thromboplastin time (aPTT) and coagulation time (CT) of groups 1 and 2.
Parameter Group 1 (N = 10) Group 2 (N = 12) P value
PT (s) 14.10 ± 0.530 14.54 ± 0.892 0.692
aPTT (s) 25.27 ± 0.546 25.00 ± 0.903 0.815
CT (min) 3.80 ± 0.239 3.72 ± 0.285 0.819
N= number of dogs in each group.
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dogs. In another research, dogs with BCS ≥ 7 had the 
leukocytes count and plasma protein concentrations 
more elavated than dogs with BCS 4-6 [19].
The dogs of group 1 and 2 did not present altera-
tions in coagulogram, due to normal values for platelets, 
PT, aPTT, CT and fibrinogen. PT evaluates the activity 
of factors VII, X, V, II and the extrinsic and common 
pathways, and aPTT, the activity of factors XII, XI, 
IX, VIII, X, and the intrinsic and common pathways of 
coagulation [5]. Moreover, fibrinogen (or factor I) is part 
of the common pathway and CT evaluates the intrinsic 
and common pathways of coagulation [24].
A recent study showed a reduced aPTT, wi-
thout difference in PT and fibrinogen concentration, 
in overweight and obese dogs, when compared to lean 
dogs [20]. In the present study, the dogs of group 2 pre-
sented PT, aPTT and CT similar to group 1; however, 
the fibrinogen concentration was higher (P < 0.05). 
Besides that, a moderate and positive correlation was 
verified between BCS and plasma fibrinogen concen-
tration in the evaluated dogs. 
Alterations in leukocytes [19] and the coagu-
logram [20] of overweight or obese dogs were related 
to a low intensity inflammatory state, evidenced by the 
increase of inflammatory markers, such as interleukin 
6 and c reactive protein, in serum of dogs [20]. Plasma 
fibrinogen is also an inflammatory marker, which may 
be increased in obese dogs [31].
There are reports that obese humans with me-
tabolic syndrome, characterized by the simultaneous 
occurrence of insulin resistance and pro-inflammatory 
status, showed an increase in the concentration of co-
agulation factors, including fibrinogen, and decreased 
in fibrinolysis. All these changes lead to a state of 
hypercoagulability, with high risk of thromboembolism 
and cardiovascular complications [11,12,18]. 
The hypothesis of a hypercoagulable state in 
overweight and obese dogs was raised by other authors, 
due to increased platelets, aPTT reduction, increased 
activity of some clotting factors (VII and X) and of 
inflammation markers [20]. However, this was not 
evidenced in the present study.
In group 2, the higher value of plasm fibrino-
gen concentration, associated with lower lymphocyte 
count, may suggest an early-stage inflammatory 
process, even in dogs in good condition. Obese dogs 
evaluated in the present study were younger (up to 10 
years old) than obese dogs assessed in previous stu-
dies (up to 15 years old) [19,20]. It is possible that the 
excess of body fat has not yet caused an inflammatory 
process as intense as that observed by these authors 
[19,20]. With the maintenance of the disease and 
over time, more evident leukocytes and coagulogram 
alterations could be observed, besides the increase of 
plasma fibrinogen. In agreement with this possibility, 
the increase of plasma fibrinogen, with normal reac-
tive protein, was observed in obese Beagles of up to 
10 years of age, suggesting a mild inflammation [31]. 
However, the consequences of increased fibrinogen in 
obese dogs are not yet well established.
CONCLUSION
The accumulation of body fat did not alter the 
erythrogram and the activity of the clotting factors, 
estimated by PT, aPTT and CT, but it interfered in the 
leukogram and increased the plasma concentration of 
fibrinogen in the evaluated dogs.
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